BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 33033346)

  • 1. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism.
    Blasco H; Bessy C; Plantier L; Lefevre A; Piver E; Bernard L; Marlet J; Stefic K; Benz-de Bretagne I; Cannet P; Lumbu H; Morel T; Boulard P; Andres CR; Vourc'h P; Hérault O; Guillon A; Emond P
    Sci Rep; 2020 Oct; 10(1):16824. PubMed ID: 33033346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Modeling of Quantitative Plasma Lipoprotein, Metabolic, and Amino Acid Data Reveals a Multiorgan Pathological Signature of SARS-CoV-2 Infection.
    Kimhofer T; Lodge S; Whiley L; Gray N; Loo RL; Lawler NG; Nitschke P; Bong SH; Morrison DL; Begum S; Richards T; Yeap BB; Smith C; Smith KGC; Holmes E; Nicholson JK
    J Proteome Res; 2020 Nov; 19(11):4442-4454. PubMed ID: 32806897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
    Barberis E; Timo S; Amede E; Vanella VV; Puricelli C; Cappellano G; Raineri D; Cittone MG; Rizzi E; Pedrinelli AR; Vassia V; Casciaro FG; Priora S; Nerici I; Galbiati A; Hayden E; Falasca M; Vaschetto R; Sainaghi PP; Dianzani U; Rolla R; Chiocchetti A; Baldanzi G; Marengo E; Manfredi M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33207699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status.
    Thomas T; Stefanoni D; Reisz JA; Nemkov T; Bertolone L; Francis RO; Hudson KE; Zimring JC; Hansen KC; Hod EA; Spitalnik SL; D'Alessandro A
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32559180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
    Li Y; Yao L; Li J; Chen L; Song Y; Cai Z; Yang C
    J Med Virol; 2020 Jul; 92(7):903-908. PubMed ID: 32219885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
    Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
    EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of SARS-CoV-2 circulation before identification of the first Swiss SARS-CoV-2 case.
    Lhopitallier L; Brahier T; Opota O; Kronenberg A; Mueller Y; Hügli O; Jaton K; Boillat-Blanco N
    Int J Antimicrob Agents; 2020 Sep; 56(3):106100. PubMed ID: 32682947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection virological diagnosis.
    Thabet L; Mhalla S; Naija H; Jaoua MA; Hannachi N; Fki-Berrajah L; Toumi A; Karray-Hakim H
    Tunis Med; 2020 Apr; 98(4):304-308. PubMed ID: 32395793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).
    Ciaccio M; Agnello L
    Diagnosis (Berl); 2020 Nov; 7(4):365-372. PubMed ID: 32589600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of patients with sickle cell disease and COVID-19: a French experience.
    Arlet JB; de Luna G; Khimoud D; Odièvre MH; de Montalembert M; Joseph L; Chantalat-Auger C; Flamarion E; Bartolucci P; Lionnet F; Monnier S; Guillaumat C; Santin A
    Lancet Haematol; 2020 Sep; 7(9):e632-e634. PubMed ID: 32563282
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Performance of SARS-CoV-2 Molecular Tests.
    Green DA; Zucker J; Westblade LF; Whittier S; Rennert H; Velu P; Craney A; Cushing M; Liu D; Sobieszczyk ME; Boehme AK; Sepulveda JL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32513858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chilblains and COVID19 infection: Causality or coincidence? How to proceed?
    Pistorius MA; Blaise S; Le Hello C; ; Barbarot S; Dréno B
    J Med Vasc; 2020 Jul; 45(4):221-223. PubMed ID: 32571563
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.
    Porte L; Legarraga P; Vollrath V; Aguilera X; Munita JM; Araos R; Pizarro G; Vial P; Iruretagoyena M; Dittrich S; Weitzel T
    Int J Infect Dis; 2020 Oct; 99():328-333. PubMed ID: 32497809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.
    Álvarez-Díaz DA; Franco-Muñoz C; Laiton-Donato K; Usme-Ciro JA; Franco-Sierra ND; Flórez-Sánchez AC; Gómez-Rangel S; Rodríguez-Calderon LD; Barbosa-Ramirez J; Ospitia-Baez E; Walteros DM; Ospina-Martinez ML; Mercado-Reyes M
    Infect Genet Evol; 2020 Oct; 84():104390. PubMed ID: 32505692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SARS-CoV-2 clusters from symptomatic cases in India.
    Jain P; Prakash O; Nyayanit DA; Verma AK; Yadav PD; Khan DN; Prakash S; Mishra H; Reddy H; Agarwal A; Bhatt MB; Jain A
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):111-115. PubMed ID: 32859867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.